Advances in Healthcare to Boost Flow Cytometry Market

Published On : Jan 15, 2019 | Category : Healthcare

Flow cytometry is a bio-physical, laser-based legitimate process that measures and breaks down various features of cells in a liquid, while outperformed through a laser shaft. Flow cytometry has different advantages over customary scientific methodologies. Together with elisa, this fuses its capacity to convey explicit and right results, and lesser time utilization at roughly square with costs. The flow cytometry innovation is extensively utilized in different fields of instructive and medical analyis. It diagnoses several ailments, instance, HIV, malignancies and hematological infections. 

According to TMR, the global flow cytometry market is anticipated to rise at a CAGR of 11.0% over the forecast period 2017 to 2025. The market is expected to rise to gain a revenue of US$8100 mn by 2025, rising from US$3,072 mn as estimated in 2016. 

Rising Incidence of Chronic Ailments to Boost Growth 

The rising number of patients experiencing HIV and malignant tumor, and expanding utilization of flow cytometry in clinics and demonstrative focuses, has made a looming requirement for flow cytometry in the powerful determination and additionally observing of illnesses. The term flow cytometry and in addition fluorescence-actuated cell arranging are frequently exchangeable. FACS or fluorescence actuated cell arranging utilized in flow cytometry have guaranteed a solid market future. There is a normal potential for growth in the flow cytometry market for immature microorganism treatment in the coming years. Increment in subsidizing from government and private associations for stem cell research is likewise another factor that is expected to impel the market growth. 

The key elements driving the growth of the market contemplated are the growing business use of new advancements in the field of flow cytometry, expanding uses of flow cytometry in clinical research, and rising use of flow cytometry in stem cell research. 

North America to Remain Lucrative Regional Market 

The United States, in the North American area, commands the market of flow cytometry because of the presence of strong government approaches for the improvement of trend setting innovations for health care. North America is trailed by Europe and Asia-Pacific. Asia-Pacific is expected to observe a noteworthy growth rate in the coming years.

 The market is focused in nature as key players are engaged with product improvement and organization partnerships to help market infiltration. Emerging number of re-appropriating specialist co-ops are expected to build industry competition soon. Industry players are picking up market traction by setting up production facilities in untapped regions of emerging markets.

Bio-Rad Laboratories, Inc., Merck KGaA, Sysmex Partec GmbH, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., and Becton, Dickinson and Company, are some of the key vendors in the global flow cytometry market.